Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis Publisher Pubmed



Llombart V1 ; Antolinfontes A1 ; Bustamante A1 ; Giralt D1 ; Rost NS2 ; Furie K3 ; Shibazaki K4 ; Biteker M5 ; Castillo J6 ; Rodriguezyanez M6 ; Fonseca AC7 ; Watanabe T8 ; Purroy F9 ; Zhixin W10 Show All Authors
Authors
  1. Llombart V1
  2. Antolinfontes A1
  3. Bustamante A1
  4. Giralt D1
  5. Rost NS2
  6. Furie K3
  7. Shibazaki K4
  8. Biteker M5
  9. Castillo J6
  10. Rodriguezyanez M6
  11. Fonseca AC7
  12. Watanabe T8
  13. Purroy F9
  14. Zhixin W10
  15. Etgen T11
  16. Hosomi N12
  17. Jafarian Kerman SR13
  18. Sharma JC14, 15
  19. Knauer C16
  20. Santamarina E17
  21. Giannakoulas G18
  22. Garciaberrocoso T1
  23. Montaner J1
Show Affiliations
Authors Affiliations
  1. 1. Neurovascular Research Laboratory, Institut de Recerca Vall d'Hebron, Neurovascular Unit, Department of Neurology, Universitat Autonoma de Barcelona, Pg. Vall d'Hebron 119-129, Barcelona, 08035, Spain
  2. 2. Acute Stroke Services, Massachusetts General Hospital, J. Philip Kistler Stroke Research Center, Boston, United States
  3. 3. Department of Neurology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, United States
  4. 4. Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan
  5. 5. Department of Cardiology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey
  6. 6. Department of Neurology, Clinical University, Hosp. University of Santiago de Compostela, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
  7. 7. Department of Neurosciences (Neurology), Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal
  8. 8. Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  9. 9. Department of Neurology, Stroke Unit, Hospital Universitari Arnau de Vilanova, Grup Neurociencies Cliniques IRBLleida, Lleida, Spain
  10. 10. Department of Emergency Medicine, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong, China
  11. 11. Department of Neurology, Kliniken Sudostbayern-Klinikum Traunstein, Traunstein, Germany
  12. 12. Department of Psychiatry and Psychotherapy, Technische Universitat Munchen, Munchen, Germany
  13. 13. Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan
  14. 14. Tehran University of Medical Sciences and Health Services, Tehran, Iran
  15. 15. Stroke and Parkinson's Disease Services, Lincoln County Hospital, University of Nottingham, Nottingham, United Kingdom
  16. 16. Department of Neurology, University of Ulm, Ulm, Germany
  17. 17. Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Barcelona, Spain
  18. 18. Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece

Source: Stroke Published:2015


Abstract

Background and Purpose - Determining the underlying cause of stroke is important to optimize secondary prevention treatment. Increased blood levels of natriuretic peptides (B-type natriuretic peptide/N-terminal pro-BNP [BNP/NT-proBNP]) have been repeatedly associated with cardioembolic stroke. Here, we evaluate their clinical value as pathogenic biomarkers for stroke through a literature systematic review and individual participants' data meta-analysis. Methods - We searched publications in PubMed database until November 2013 that compared BNP and NT-proBNP circulating levels among stroke causes. Standardized individual participants' data were collected to estimate predictive values of BNP/NT-proBNP for cardioembolic stroke. Dichotomized BNP/NT-proBNP levels were included in logistic regression models together with clinical variables to assess the sensitivity and specificity to identify cardioembolic strokes and the additional value of biomarkers using area under the curve and integrated discrimination improvement index. Results - From 23 selected articles, we collected information of 2834 patients with a defined cause. BNP/NT-proBNP levels were significantly elevated in cardioembolic stroke until 72 hours from symptoms onset. Predictive models showed a sensitivity >90% and specificity >80% when BNP/NT-proBNP were added considering the lowest and the highest quartile, respectively. Both peptides also increased significantly the area under the curve and integrated discrimination improvement index compared with clinical models. Sensitivity, specificity, and precision of the models were validated in 197 patients with initially undetermined stroke with final pathogenic diagnosis after ancillary follow-up. Conclusions - Natriuretic peptides are strongly increased in cardioembolic strokes. Future multicentre prospective studies comparing BNP and NT-proBNP might aid in finding the optimal biomarker, the best time point, and the optimal cutoff points for cardioembolic stroke identification. © 2015 American Heart Association, Inc.